AMCP Guidance for Submission of Clinical and Economic Evaluation Data to Support Formulary Listing in U.S. Health Plans and Pharmacy Benefits Management Organizations

Journal of Managed Care Pharmacy
doi 10.18553/jmcp.2001.7.4.272
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Academy of Managed Care Pharmacy

Related search

Bridging the Gap: Collaboration Between a School of Pharmacy, Public Health, and Governmental Organizations to Provide Clinical and Economic Services to Medicare Beneficiaries

INNOVATIONS in pharmacy
2018English

Risks and Benefits of Risk-Management Plans

Health Affairs
MedicineHealth Policy
2007English

Effect of Cinacalcet Availability and Formulary Listing on Parathyroidectomy Rate Trends

BMC Nephrology
Nephrology
2013English

Key Clinical Indicators for Sexual Health: Current National Sexual Health Data Collection and Future Plans

2012English

Clinical Pharmacy and Hospital Drug Management

Postgraduate Medical Journal
Medicine
1982English

Evaluation of Clinical and Administrative Data to Augment Public Health Surveillance

Online Journal of Public Health Informatics
2013English

National Drug Policies to Local Formulary Decisions in Thailand, China, and Australia: Drug Listing Changes and Opportunities

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Ontology-Based Decision Support Systems for Health Data Management to Support Collaboration in Ambient Assisted Living and Work Reintegration

IFIP Advances in Information and Communication Technology
Computer NetworksInformation SystemsManagementCommunications
2017English

Accountable Care Organizations: The Case for Flexible Partnerships Between Health Plans and Providers

Health Affairs
MedicineHealth Policy
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy